Tango Therapeutics Inc (TNGX)

EBITDA Growth

-43.78%

Quarterly · Period ending:

TNGX logo

TNGX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-43.78%
TNGX Quarterly EBITDA YoY % (-49.72% → -43.78%)
High-resolution chart · PNG

TNGX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tango Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-43.7829%
-14.8649%
-3.5783%
157.6638%
-53.6694%
-5.2914%
-22.931%
-31.7381%
-24.0096%
-35.8114%
-5.8371%
24.4683%
18.3392%
-10.153%
-31.5828%
-48.3345%
-470.5021%
-110.509%
-149.1699%
27.3504%
47.9555%
-49.7215%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.